Slideshow
Our October list of news and research includes FDA approval of a new weight loss device, a comparison of canagliflozin & glimepiride, and more.
We present a selection of interesting news and research for the month of October focusing on type 2 diabetes. See the slide legends for links to the article summaries.Be on the lookout for our regular Interesting Endocrinology series later this month, which will cover type 1 diabetes and other endocrine disorders.Â